{"nct_id":"NCT03635567","title":"Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2018-10-25","start_date_type":"ACTUAL","primary_completion_date":"2022-10-03","primary_completion_date_type":"ACTUAL","completion_date":"2024-06-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}